SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022829
Filing Date
2020-05-07
Accepted
2020-05-07 16:06:16
Documents
46
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20200331.htm 10-Q 811558
2 EX-31.1 mack-ex311_8.htm EX-31.1 9542
3 EX-31.2 mack-ex312_9.htm EX-31.2 9531
4 EX-32.1 mack-ex321_7.htm EX-32.1 5717
5 EX-32.2 mack-ex322_6.htm EX-32.2 5717
  Complete submission text file 0001564590-20-022829.txt   2925067

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20200331.xml EX-101.INS 504425
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20200331.xsd EX-101.SCH 30637
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20200331_cal.xml EX-101.CAL 29389
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20200331_def.xml EX-101.DEF 72810
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20200331_lab.xml EX-101.LAB 222229
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20200331_pre.xml EX-101.PRE 161347
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 20856311
SIC: 2834 Pharmaceutical Preparations